Philips and Rennes University Hospital sign 5-year technology, research and innovation partnership to advance patient care
January 25 2021 - 2:00AM
Philips and Rennes University Hospital sign 5-year technology,
research and innovation partnership to advance patient care
January 25, 2021
- Hospital will have access to Philips’ latest technologies and
informatics solutions to enhance the diagnosis, treatment,
monitoring and management of patients
- Multi-year strategic partnership will accelerate clinical
research focused on image-guided minimally-invasive therapy,
neurology, intensive care units and digital pathology
Amsterdam, the Netherlands – Royal Philips
(NYSE: PHG, AEX: PHIA), a global leader in health technology, and
Rennes University Hospital, one of France’s leading hospitals in
image-guided interventions, robotics and clinical research, today
announced the signing of a 5-year technology and innovation
partnership to support diagnostic, interventional imaging and
patient monitoring and management, undertake clinical research, and
leverage Philips’ and Rennes University Hospital’s ecosystems of
open innovation to foster French start-up companies.
Philips will deliver new medical technologies and provide
management and maintenance services for the hospital’s diagnostic
and interventional imaging modalities (MRI, CT, and image-guided
therapy) as well as patient monitoring. Informatics solutions will
offer central, high-resolution data capture and storage (data
warehouses) to drive quality and efficiency improvements, and
comprehensive visualization and analysis tools to enhance
diagnostic confidence for complex medical cases. Philips
Healthcare Transformation Services experts will help to optimize
the hospital’s clinical pathways and patient experience, especially
for intensive care units (ICUs) and neuro-radiology
departments.
“Philips and Rennes University Hospital are entering into a
ground-breaking partnership aimed at significantly improving the
stroke pathway and co-developing AI algorithms to improve care for
the most acute patients, particularly those in the ICU,” said David
Corcos, General Manager Philips France. “Leveraging the hospital’s
clinical expertise and our respective innovation ecosystems, we
believe we can jointly innovate to help the hospital’s healthcare
professionals improve care and outcomes for their patients, while
contributing to a more sustainable healthcare system. We are
thrilled by this unique opportunity.”
Research and innovationKey elements of the
partnership are collaborative research and innovation activities
focused on areas that combine Philips’ technological expertise with
Rennes University Hospital’s clinical expertise. Co-development
projects will focus on several key areas of joint strategic
interest – optimized stroke management, robotics for neurological
interventions, big data analytics and artificial intelligence (AI)
for monitoring patients in ICUs, and AI algorithms to support
digital pathology. In addition, the hospital will have access to
Philips’ in-house expertise and open-innovation ecosystem to foster
the creation of French tech start-ups that can translate research
into clinical solutions.
“The University Hospital of Rennes is particularly glad to join
its forces with Philips in the framework of an original and
ambitious partnership, unique in France, offering tremendous
opportunities for innovation and co-development of new solutions to
shape the future of medicine and patient care,” said Véronique
Anatole-Touzet, CEO at Rennes University Hospital. “This
collaboration is the result of several years of fruitful
collaboration. Thanks to its rich and integrated character, this
partnership will be an amazing catalyst for innovation and research
for the University Hospital of Rennes.”
Rennes University Hospital, with more than 1,800 beds shared
among 4 different sites, is one of the top 10 hospitals in France
and a reference center in cardiac and vascular surgery,
transplantation, next to other specialisms such as neurosurgery,
neuroradiology and robotics. In terms of research and innovation,
it has around 200 professionals involved in more than 1,700
research projects shared among 14 research units. Philips and
Rennes University Hospital already have multiple collaborations in
the field of medical imaging, plus an innovation partnership in
digital pathology - the first of its kind in France. Today’s
strategic partnership also includes two associate partners of the
University Hospital – the University of Rennes 1 and the
Saint-Laurent polyclinic.
For further information, please contact:
Joost MalthaPhilips Global Press OfficeTel.: +31 6 10 55 81
16E-mail: joost.maltha@philips.com
Elise DecencierePhilips France media relations managerTel : +33
6 49 20 18 50E-mail: elise.decenciere@philips.com
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health
technology company focused on improving people's health and
well-being, and enabling better outcomes across the health
continuum – from healthy living and prevention, to diagnosis,
treatment and home care. Philips leverages advanced technology and
deep clinical and consumer insights to deliver integrated
solutions. Headquartered in the Netherlands, the company is a
leader in diagnostic imaging, image-guided therapy, patient
monitoring and health informatics, as well as in consumer health
and home care. Philips generated 2020 sales of EUR 19.5 billion and
employs approximately 82,000 employees with sales and services in
more than 100 countries. News about Philips can be found at
www.philips.com/newscenter.
- Philips Azurion with Flexarm
Koninklijke Philips NV (EU:PHIA)
Historical Stock Chart
From Apr 2024 to May 2024
Koninklijke Philips NV (EU:PHIA)
Historical Stock Chart
From May 2023 to May 2024